Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies' combined specialty drug sales were about $4.3 bil. in 2004. The acquisition puts Medco in a position to take a large share of Medicare Part B drug business in addition to its stake in the Part D outpatient drug benefit.